Source: Annual Congress 2001 - Molecular associations with TB
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Cikirikcioglu, B. Komurcuoglu, A. Atay, M. Buyuksirin, S. Aktogu, E. Celikten, K. Perim (Izmir, Turkey). The effect of antituberculosis chemotherapy on thyroid hormones in active pulmonary tuberculosis patients. Eur Respir J 2001; 16: Suppl. 31, 2027

Member's Comments

No comment yet.

Related content which might interest you: Side effects of antituberculosis drugs in treatment of patients with newly detected pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 197s Year: 2007 The effect of anti-tuberculosis chemotherapy using second-line drugs on the structural and functional state of the thyroid gland Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Side-effect in the treatment of pulmonary tuberculosis by first-line drugs Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 Antituberculous activity of fiurenizid in vitro and in patients with destructive pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 724s Year: 2004 Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Diaskintest at patients after successful treatment of lung tuberculosis Source: International Congress 2017 – Migrants and screening Year: 2017 Efficacy of standard chemotherapy regimen in patients with newly detected sputum-positive destructive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003 Treatment results in patients with drug resistant pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002 Isoniazid resistance is associated with delayed culture conversion during anti-tuberculosis treatment among patients with pulmonary tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 A study of role of rifabutin as an adjuvant in management of cases with multi-drug resistant pulmonary tuberculosis Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 On questions of pulmonary tuberculosis relapses among patients completed the directly observed short-course chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005 Do empiric antibiotics delay appropriate antituberculosis medication in patients with active pulmonary tuberculosis? Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 Dynamics of production thyroid-stimulating hormone in patients with multiple-drug resistant tuberculosis (MDR-TB) on the background of prolonged chemotherapy Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Effect of treatment of drug resistant tuberculosis on thyroid stimulating hormone Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Antituberculosis activity of rifabutin in vitro and in patients with pulmonary drug resistant tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003 Response of pulmonary tuberculomas to anti-tuberculous treatment Source: Eur Respir J 2004; 23: 452-455 Year: 2004 Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Treatment results of new cases of sputum-positive pulmonary tuberculosis with standard chemotherapeutical regimen Source: Eur Respir J 2002; 20: Suppl. 38, 367s Year: 2002